Conference Session on Demand
dates for CE credit: 8/13/2020
cannot earn this CE if you already earned it at the virtual ADCES20 annual conference*
Chronic kidney disease (CKD) occurs in 20–40% of people with diabetes and is the leading cause of end-stage renal disease in the U.S. The presence of CKD significantly increases the risk of cardiovascular events and health care expenditures. Several glucose lowering medications have positive effects on renal function independent of glucose-lowering activity. This session reviews medication recommendations and monitoring strategies for glucose lowering medications for individuals with diabetes and CKD.
At the end of this presentation,
participants will be able to:
-- Describe how diabetes affects the development of chronic kidney disease
-- Discuss medication selection for individuals with diabetes and chronic kidney disease
-- State monitoring strategies for antihyperglycemic medications in individuals with diabetes and chronic kidney disease
of a live presentation is a
knowledge-based learning activity.
ADCES Webinars are designed for
individual or groups of diabetes care and education specialists, including nurses,
dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners,
clinical nurse specialists, physicians, PAs, and other health care providers
interested in staying up to date on current practices of care for people with
diabetes and other related conditions.
Lourdes Cross, PharmD, BCACP, CDCES
Clinical Assistant Professor
Sullivan University College of Pharmacy & Health Sciences
support of improving patient care, the Association of Diabetes Care &
Education Specialists is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy
Education (ACPE), and the American Nurses Credentialing Center (ANCC) to
provide continuing education for the healthcare team.
Council for Pharmacy Education (ACPE)
Universal Activity Number is JA4008258-0000-21-088-H01-P.
activity has been approved for 0.5 contact hour(s).
This statement contains information provided to NABP from
the Accreditation Council for Pharmacy Education (ACPE) via CPE
Monitor®. ACPE policy states paper and/or
electronic statements of credit may no longer be distributed directly to learners
as proof of ACPE credit. The official record of credit may be located in the
learner’s e-profile in CPE Monitor.
Medical Association (AMA)
of Diabetes Care & Education Specialists designates this enduring
material for a maximum of 0.5
AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this
activity for a maximum of 0.5
ANCC contact hour(s). This activity discusses 0.5 contact hour(s) of pharmacotherapeutic
Association of Diabetes Care & Education Specialists is approved by the
California Board of Registered Nursing, Provider Number 10977, for 0.5 contact
Academy of PAs (AAPA)
Association of Diabetes Care & Education Specialists has been
authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME
credit for activities planned in accordance with AAPA CME Criteria. This
activity is designated for 0.5
AAPA Category 1 CME credit(s). Approval is valid until 8/13/22. PAs should only claim credit
commensurate with the extent of their participation.
on Dietetic Registration (CDR)
Credentialed Practitioners will receive 0.5 Continuing Professional Education unit(s) (CPEU)
for completion of this activity.
Completion of this RD/DTR profession-specific or IPCE
activity awards CPEUs (One IPCE credit = One CPEU). If the activity is
dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which
are commensurate with participation in contact hours (One 60 minute hour = 1
CPEU. RDs and DTRs are to select activity type 102 in their Activity Log.
Performance Indicator selection is at the learner’s
Certified Diabetes Care and Education
To satisfy the requirements for renewal
of certification for the Certification Board for Diabetes Care and Education
(CBDCE), continuing education activities must be diabetes related and approved
by a provider on the CBDCE list of Approved Providers (www.cbdce.org).
CBDCE does not approve continuing education. The Association of Diabetes Care
& Education Specialists is on the CBDCE list of Approved
Board Certified Advanced Diabetes
ADCES is the administering body for the
Advanced Diabetes Management credentials. Continuing education programs offered
by ADCES can be used toward fulfilling BC-ADM Certification and recertification
is the responsibility of each participant to determine if the program meets the
criteria for re-licensure or recertification for their discipline.
In accordance with
Joint Accreditation criteria, the Association of Diabetes Care & Education
Specialists (ADCES) must ensure that anyone in a position to control the
content of the educational activity (planners and
speakers/authors/discussants/moderators) has disclosed all relevant financial
relationships with any commercial interest.
also requires that ADCES manage any reported conflict and eliminate the
potential for bias during the educational activity. Any conflicts noted below
have been managed to our satisfaction. The disclosure information is intended
to identify any commercial relationships and allow learners to form their own
judgments. However, if you perceive a bias during an activity, please report it
on the evaluation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Lourdes Cross, PharmD, BCACP, CDCES, has no relevant
financial disclosures to report.
Jodi Lavin-Tompkins, MSN, RN, CDCES,
BC-ADM, has no relevant financial disclosures to report.
Rinker, MS, RDN, CDCES, LDN, FADCES, has no relevant financial disclosures to
D. Ward, PharmD, BCACP, TTS, has no relevant financial disclosures to report.
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure of Relevant Financial
Relationships and Mechanism to Identify and Resolved Conflicts of
Undertaking review of the educational
activity to evaluate for potential bias, balance in presentation,
evidence-based content or other indicators of integrity, and absence of
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity's CE credits expire (whichever comes
discounts are available and will be automatically applied at check-out when the
desired quantity is selected
of 4-9: 10% off
Groups of 10-19: 20% off
Groups of 20-29: 30% off
Groups of 30+: Contact firstname.lastname@example.org to get a custom quote.
CBs and LNGs: Please contact us at email@example.com to order a
recorded webinar for a group viewing.